ANT308 is an antagonist of the vasoactive intestinal peptide (VIP receptor). It significantly enhances T cell activation and proliferation. By inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin, ANT308 suppresses melanoma cell migration and metastasis while inducing apoptosis. This compound is useful for research in acute myeloid leukemia (AML) and uveal melanoma (UVM).
Molekulargewicht:
3467.15
CAS Nummer:
[2871680-36-1]
Formel:
C156H261N47O40S
Target-Kategorie:
Apoptosis|||PACAP
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
